Vermilion Therapeutics aims to create innovative new drugs from
Japanese science, and aims to innovate new modality and technology
in collaboration with academia science.
NEWS
-
Sep. 28, 2022
”2022 Best Paper Award” from Japanese Society of Medical Mycology
-
Jul. 19, 2022
Research team from Vermilion Therapeutics Inc. and University of Tokyo, has joined Award-Reception of “Cutting-Edge technology” Award
-
Jun. 09, 2022
Vermilion Therapeutics Inc., University of Tokyo, and Wakayama Medical Univ. has received the “Special Award of Cutting-Edge Technology”
PROJECT
Vermilion Therapeutics Inc. is aiming to research and develop new treatments for Alzheimer’s disease, Cardiac and Kidney Amyloidosis, Corona virus infections (SARS-CoV-2), and Solid tumors and malignant cancer.
